TCM
CRL icon

Twin Capital Management’s Charles River Laboratories CRL Stock Holding History

Twin Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
+7,367
New +$1.31M 0.18% 121
2013
Q3 		– Sell
-9,820
Closed -$403K – 325
2013
Q2 		$403K Buy
+9,820
New +$421K 0.04% 309

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Twin Capital Management's CRL Position: Q2 2026 in Review

Twin Capital Management opened a new position in Charles River Laboratories (CRL) in Q2 2026: 7,367 shares worth $1.67M. The stake represents 0.18% of the portfolio and ranks #121 among its holdings. This is a return to the name: Twin Capital Management previously reported a position in CRL as recently as Q2 2013.

Twin Capital Management first reported a position in CRL in Q2 2013 and has held it in 2 quarters since. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Twin Capital Management held 7,367 shares of Charles River Laboratories worth $1.67M as of Q2 2026.
  • Charles River Laboratories was a new Twin Capital Management position in Q2 2026.
  • Charles River Laboratories made up 0.18% of Twin Capital Management's portfolio in Q2 2026, its #121 holding.
  • Twin Capital Management first reported a position in Charles River Laboratories in Q2 2013 and has held it in 2 quarters since.
  • 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Twin Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.